Pacira BioSciences Inc. (PCRX)
25.75
-0.29 (-1.11%)
At close: Feb 20, 2025, 3:59 PM
25.74
-0.06%
After-hours: Feb 20, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 24 |
| Market Cap | 1.19B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.98 |
| PE Ratio (ttm) | -13.01 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 26.9 |
| Volume | 355,388 |
| Avg. Volume (20D) | 817,454 |
| Open | 25.87 |
| Previous Close | 26.04 |
| Day's Range | 25.69 - 26.27 |
| 52-Week Range | 11.16 - 31.67 |
| Beta | undefined |
About PCRX
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted ner...
Sector Healthcare
IPO Date Feb 3, 2011
Employees 711
Stock Exchange NASDAQ
Ticker Symbol PCRX
Website https://www.pacira.com
Analyst Forecast
According to 9 analyst ratings, the average rating for PCRX stock is "Hold." The 12-month stock price forecast is $25, which is a decrease of -2.93% from the latest price.
Buy 55.56%
Hold 33.33%
Sell 11.11%
Next Earnings Release
Pacira BioSciences Inc. is scheduled to release its earnings on Feb 27, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+11.09%
Pacira Biosciences shares are trading higher after...
Unlock content with
Pro Subscription
6 months ago
-47.67%
Pacira BioSciences shares are trading lower after the U.S. District Court for the District of New Jersey found that Patent No. 11,033,495 is not valid. CEO Frank D. Lee stated that the company is considering its legal options, including pursuing an appellate review at the U.S. Court of Appeals for the Federal Circuit if warranted.
